Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03328026 |
| Title | Rollover Study of SV-BR-1-GM in Combination With Ipilimumab or Pembrolizumab |
| Recruitment | Enrolling by invitation |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BriaCell Therapeutics Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |